Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Moore

Showing results (191-200 of 235) with videos related to

Pageof 24
Sort By:
The New England Journal of Medicine|May 1, 1998
Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology GroupM E Gleave, M Elhilali, Y Fradet, et al.
Heart (British Cardiac Society)|June 9, 2005
Demographic and temporal trends in out of hospital sudden cardiac death in BelfastM J Moore, B M Glover, C J McCann, et al.
Proceedings. Biological Sciences|October 14, 2011
Bubbles in live-stranded dolphinsS Dennison, M J Moore, A Fahlman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 4, 1999
A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine bindingS E Howie, M L Fernandes, I Heslop, et al.
Clinical Colorectal Cancer|November 28, 2002
The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian TrialM Michael, D Hedley, A Oza, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1990
Phase II study of trimetrexate in recurrent anaplastic glioma. National Cancer Institute of Canada Clinical Trials Group StudyJ G Cairncross, E A Eisenhauer, D R Macdonald, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placeboM M Vickers, E D Powell, T R Asmis, et al.
RSC Advances|May 11, 2022
Bis-phenylethynyl polyhedral oligomeric silsesquioxanes: new high-temperature, processable thermosetting materialsLevi M J Moore, Jacob J Zavala, Jason T Lamb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and painD S Ernst, I F Tannock, E W Winquist, et al.
Heart (British Cardiac Society)|January 31, 2008
The Northern Ireland Public Access Defibrillation (NIPAD) study: effectiveness in urban and rural populationsM J Moore, A J Hamilton, K J Cairns, et al.
Pageof 24

Showing results (191-200 of 235) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|May 1, 1998
Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology GroupM E Gleave, M Elhilali, Y Fradet, et al.
Heart (British Cardiac Society)|June 9, 2005
Demographic and temporal trends in out of hospital sudden cardiac death in BelfastM J Moore, B M Glover, C J McCann, et al.
Proceedings. Biological Sciences|October 14, 2011
Bubbles in live-stranded dolphinsS Dennison, M J Moore, A Fahlman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 4, 1999
A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine bindingS E Howie, M L Fernandes, I Heslop, et al.
Clinical Colorectal Cancer|November 28, 2002
The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian TrialM Michael, D Hedley, A Oza, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1990
Phase II study of trimetrexate in recurrent anaplastic glioma. National Cancer Institute of Canada Clinical Trials Group StudyJ G Cairncross, E A Eisenhauer, D R Macdonald, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placeboM M Vickers, E D Powell, T R Asmis, et al.
RSC Advances|May 11, 2022
Bis-phenylethynyl polyhedral oligomeric silsesquioxanes: new high-temperature, processable thermosetting materialsLevi M J Moore, Jacob J Zavala, Jason T Lamb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and painD S Ernst, I F Tannock, E W Winquist, et al.
Heart (British Cardiac Society)|January 31, 2008
The Northern Ireland Public Access Defibrillation (NIPAD) study: effectiveness in urban and rural populationsM J Moore, A J Hamilton, K J Cairns, et al.
Pageof 24